Nestoras N Mathioudakis1, Mohammed S Abusamaan1, Ahmed F Shakarchi2, Sam Sokolinsky3, Shamil Fayzullin3, John McGready4, Mihail Zilbermint1,5, Suchi Saria6, Sherita Hill Golden1. 1. Division of Endocrinology, Diabetes & Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland. 2. Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland. 3. Department of Quality Improvement and Clinical Analytics, Johns Hopkins Health System, Baltimore, Maryland. 4. Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 5. Johns Hopkins Community Physicians at Suburban Hospital, Suburban Hospital, Bethesda, Maryland. 6. Departments of Computer Science, Applied Math and Statistics, and Health Policy, Johns Hopkins University, Baltimore, Maryland.
Abstract
Importance: Accurate clinical decision support tools are needed to identify patients at risk for iatrogenic hypoglycemia, a potentially serious adverse event, throughout hospitalization. Objective: To predict the risk of iatrogenic hypoglycemia within 24 hours after each blood glucose (BG) measurement during hospitalization using a machine learning model. Design, Setting, and Participants: This retrospective cohort study, conducted at 5 hospitals within the Johns Hopkins Health System, included 54 978 admissions of 35 147 inpatients who had at least 4 BG measurements and received at least 1 U of insulin during hospitalization between December 1, 2014, and July 31, 2018. Data from the largest hospital were split into a 70% training set and 30% test set. A stochastic gradient boosting machine learning model was developed using the training set and validated on internal and external validation. Exposures: A total of 43 clinical predictors of iatrogenic hypoglycemia were extracted from the electronic medical record, including demographic characteristics, diagnoses, procedures, laboratory data, medications, orders, anthropomorphometric data, and vital signs. Main Outcomes and Measures: Iatrogenic hypoglycemia was defined as a BG measurement less than or equal to 70 mg/dL occurring within the pharmacologic duration of action of administered insulin, sulfonylurea, or meglitinide. Results: This cohort study included 54 978 admissions (35 147 inpatients; median [interquartile range] age, 66.0 [56.0-75.0] years; 27 781 [50.5%] male; 30 429 [55.3%] White) from 5 hospitals. Of 1 612 425 index BG measurements, 50 354 (3.1%) were followed by iatrogenic hypoglycemia in the subsequent 24 hours. On internal validation, the model achieved a C statistic of 0.90 (95% CI, 0.89-0.90), a positive predictive value of 0.09 (95% CI, 0.08-0.09), a positive likelihood ratio of 4.67 (95% CI, 4.59-4.74), a negative predictive value of 1.00 (95% CI, 1.00-1.00), and a negative likelihood ratio of 0.22 (95% CI, 0.21-0.23). On external validation, the model achieved C statistics ranging from 0.86 to 0.88, positive predictive values ranging from 0.12 to 0.13, negative predictive values of 0.99, positive likelihood ratios ranging from 3.09 to 3.89, and negative likelihood ratios ranging from 0.23 to 0.25. Basal insulin dose, coefficient of variation of BG, and previous hypoglycemic episodes were the strongest predictors. Conclusions and Relevance: These findings suggest that iatrogenic hypoglycemia can be predicted in a short-term prediction horizon after each BG measurement during hospitalization. Further studies are needed to translate this model into a real-time informatics alert and evaluate its effectiveness in reducing the incidence of inpatient iatrogenic hypoglycemia.
Importance: Accurate clinical decision support tools are needed to identify patients at risk for iatrogenic hypoglycemia, a potentially serious adverse event, throughout hospitalization. Objective: To predict the risk of iatrogenic hypoglycemia within 24 hours after each blood glucose (BG) measurement during hospitalization using a machine learning model. Design, Setting, and Participants: This retrospective cohort study, conducted at 5 hospitals within the Johns Hopkins Health System, included 54 978 admissions of 35 147 inpatients who had at least 4 BG measurements and received at least 1 U of insulin during hospitalization between December 1, 2014, and July 31, 2018. Data from the largest hospital were split into a 70% training set and 30% test set. A stochastic gradient boosting machine learning model was developed using the training set and validated on internal and external validation. Exposures: A total of 43 clinical predictors of iatrogenic hypoglycemia were extracted from the electronic medical record, including demographic characteristics, diagnoses, procedures, laboratory data, medications, orders, anthropomorphometric data, and vital signs. Main Outcomes and Measures: Iatrogenic hypoglycemia was defined as a BG measurement less than or equal to 70 mg/dL occurring within the pharmacologic duration of action of administered insulin, sulfonylurea, or meglitinide. Results: This cohort study included 54 978 admissions (35 147 inpatients; median [interquartile range] age, 66.0 [56.0-75.0] years; 27 781 [50.5%] male; 30 429 [55.3%] White) from 5 hospitals. Of 1 612 425 index BG measurements, 50 354 (3.1%) were followed by iatrogenic hypoglycemia in the subsequent 24 hours. On internal validation, the model achieved a C statistic of 0.90 (95% CI, 0.89-0.90), a positive predictive value of 0.09 (95% CI, 0.08-0.09), a positive likelihood ratio of 4.67 (95% CI, 4.59-4.74), a negative predictive value of 1.00 (95% CI, 1.00-1.00), and a negative likelihood ratio of 0.22 (95% CI, 0.21-0.23). On external validation, the model achieved C statistics ranging from 0.86 to 0.88, positive predictive values ranging from 0.12 to 0.13, negative predictive values of 0.99, positive likelihood ratios ranging from 3.09 to 3.89, and negative likelihood ratios ranging from 0.23 to 0.25. Basal insulin dose, coefficient of variation of BG, and previous hypoglycemic episodes were the strongest predictors. Conclusions and Relevance: These findings suggest that iatrogenic hypoglycemia can be predicted in a short-term prediction horizon after each BG measurement during hospitalization. Further studies are needed to translate this model into a real-time informatics alert and evaluate its effectiveness in reducing the incidence of inpatient iatrogenic hypoglycemia.
Authors: Alexander Turchin; Michael E Matheny; Maria Shubina; James V Scanlon; Bonnie Greenwood; Merri L Pendergrass Journal: Diabetes Care Date: 2009-07 Impact factor: 19.112
Authors: Curtiss B Cook; Dean A McNaughton; Cathleen M Braddy; Kimberly A Jameson; Lori R Roust; Steven A Smith; Daniel L Roberts; Stephen L Thomas; Bryan P Hull Journal: Endocr Pract Date: 2007 Mar-Apr Impact factor: 3.443
Authors: Kimberly G Brodovicz; Vinay Mehta; Qiaoyi Zhang; Changgeng Zhao; Michael J Davies; Jieling Chen; Larry Radican; Samuel S Engel Journal: Curr Med Res Opin Date: 2012-12-14 Impact factor: 2.580
Authors: Johannes Roth; Oliver Sommerfeld; Andreas L Birkenfeld; Christoph Sponholz; Ulrich A Müller; Christian von Loeffelholz Journal: Dtsch Arztebl Int Date: 2021-09-17 Impact factor: 5.594
Authors: Jingtong Huang; Andrea M Yeung; Kevin T Nguyen; Nicole Y Xu; Jean-Charles Preiser; Robert J Rushakoff; Jane Jeffrie Seley; Guillermo E Umpierrez; Amisha Wallia; Andjela T Drincic; Roma Gianchandani; M Cecilia Lansang; Umesh Masharani; Nestoras Mathioudakis; Francisco J Pasquel; Signe Schmidt; Viral N Shah; Elias K Spanakis; Andreas Stuhr; Gerlies M Treiber; David C Klonoff Journal: J Diabetes Sci Technol Date: 2022-07-29
Authors: Nestoras Mathioudakis; Moeen Aboabdo; Mohammed S Abusamaan; Christina Yuan; LaPricia Lewis Boyer; Scott J Pilla; Erica Johnson; Sanjay Desai; Amy Knight; Peter Greene; Sherita H Golden Journal: JMIR Hum Factors Date: 2021-11-26
Authors: Thaer Idrees; Iris A Castro-Revoredo; Alexandra L Migdal; Emmelin Marie Moreno; Guillermo E Umpierrez Journal: BMJ Open Diabetes Res Care Date: 2022-07
Authors: William B Horton; Andrew J Barros; Robert T Andris; Matthew T Clark; J Randall Moorman Journal: Crit Care Med Date: 2022-03-01 Impact factor: 7.598